Alimetry AI Wearable Analyzes Gut Electrical Activity 

The New Zeeland-based company Alimetry LTD. developed an AI-powered wearable that analyzes gut electrical activity to offer a noninvasive gastric diagnosis for gastrointestinal diseases, providing a noninvasive alternative for personalized treatment. 

The wearable AI device works by being placed on a patient’s stomach, where it reads and records electrical signals to detect gut-related disorders like nausea and cramping. 

Using advanced AI technology, the gastric Alimetry test collects and processes the recorded data that will help physicians provide faster and more accurate diagnosis. 

Electrodes for Better AI Analysis 

Alimetry ‘s wearable gadget uses a wide range of electrodes that are placed on the stomach to be able to detect weak electrical signals through the digestive system.  

Dr. Greg O’Grady, co-founder and CEO of Alimetry, claims that although these signals are significantly more difficult to pick up, gut activity functions similarly to the heart’s natural electrical cycles. The Alimetry test eliminates “digestive noise” through AI-driven analysis, concentrating on vital information that physicians may utilize to comprehend the patient’s symptoms. 

“It’s much like the heart; the gut runs on a natural electricity, and that electricity causes it to move,” O’Grady further elaborated, adding that although this kind of activity has long been recognized, it was hard to identify until the development of wearable and artificial intelligence technology. 

Streamlined Testing and Diagnosis 

With Alimetry’s wearable device, patients spend time in the clinic wearing it while consuming a light meal to record their stomach’s electrical activity during digestion. As the stomach processes the food, the device gathers data, which is then analyzed by Alimetry’s software. 

The collected information from Alimetry’s gastric test is then transferred to a comprehensive report that physicians can use to assist in diagnosing and treating a range of gut-related diagnoses for personalized and noninvasive gastric diagnosis and care. 

In the meantime, the company is working with more than 30 hospitals across the United States, the United Kingdom, and New Zealand. Moreover, the organization has received multiple food and drug administration (FDA) clearances.  

Such a device can help a lot in treating gut-related diseases, yet it is not all-inclusive. “There’s always going to be a range of patients who require other testing,” mentions O’Grady. 

But Alimetry’s device is helping clinicians determine what might be causing stomach problems and may one day enable more automated diagnosis. 

The promising technology developed by Alimetry has also caught the attention of many investors. In 2021, the startup managed to raise $10 million and has recently received funding of $18 million in Series A funding led by VC firm GD1. 

Inside Telecom provides you with an extensive list of content covering all aspects of the tech industry. Keep an eye on our Intelligent Tech sections to stay informed and up-to-date with our daily articles.